[Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome]
- PMID: 17327030
[Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome]
Abstract
Objective: To investigate whether the limited ovarian stimulation (LOS) could avoid the severe ovarian hyperstimulation syndrome (OHSS) in patients with high risk of OHSS.
Methods: Ten infertile patients were diagnosed as polycystic ovarian syndrome (PCOS) with high risk of OHSS. All of them were arranged LOS cycles, a long-induction protocol using gonadotropin releasing hormone agonist (GnRHa) for controlled ovarian hyperstimulation. A full dose of human chorionic gonadotropin (10,000 U) was administered when the leading follicle reached a mean diameter of 12.0 - 14.5 mm. Oocytes were retrieved 36 hours later, followed by conventional in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) and embryo transfer.
Results: Ten patients produced 11 - 35 oocytes, including 4 - 28 oocytes of metaphase II. Embryos were transferred in all of ten patients and eight clinical pregnancies were diagnosed. Unfortunately, ectopic pregnancy occurred in one of the patients. None of them experienced the symptoms of OHSS.
Conclusions: LOS may play a valuable role in preventing OHSS and achieving enough mature oocytes for the patients of PCOS. Furthermore, this protocol would not reduce the pregnancy rate of the patients.
Similar articles
-
Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.Eur J Obstet Gynecol Reprod Biol. 2005 Sep 1;122(1):79-84. doi: 10.1016/j.ejogrb.2005.01.023. Eur J Obstet Gynecol Reprod Biol. 2005. PMID: 16154042 Clinical Trial.
-
[Study on clinical effect on infertility women with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer].Zhonghua Fu Chan Ke Za Zhi. 2012 Apr;47(4):250-4. Zhonghua Fu Chan Ke Za Zhi. 2012. PMID: 22781109 Chinese.
-
Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.Gynecol Endocrinol. 2006 May;22(5):235-8. doi: 10.1080/14767050600761893. Gynecol Endocrinol. 2006. PMID: 16785142 Clinical Trial.
-
Ovarian hyperstimulation syndrome prevention strategies: use of gonadotropin-releasing hormone antagonists.Semin Reprod Med. 2010 Nov;28(6):493-9. doi: 10.1055/s-0030-1265676. Epub 2010 Nov 16. Semin Reprod Med. 2010. PMID: 21082508 Review.
-
Gonadotropin-releasing hormone agonist trigger: the way to eliminate ovarian hyperstimulation syndrome--a 20-year experience.Semin Reprod Med. 2010 Nov;28(6):500-5. doi: 10.1055/s-0030-1265677. Epub 2010 Nov 16. Semin Reprod Med. 2010. PMID: 21082509 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources